The DOI matches its Crossref record; 319 of the 319 references it cites were found in a registry or an index.
A comprehensive review of amyotrophic lateral sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a late-onset fatal neurodegenerative disease affecting motor neurons with an incidence of about 1/100,000. Most ALS cases are sporadic, but 5-10% of the cases are familial ALS. Both sporadic and familial ALS (FALS) are associated with degeneration of cortical and spinal motor neurons. The etiology of ALS remains unknown. However, mutations of superoxide dismutase 1 have been known as the most common cause of FALS. In this study, we provide a comprehensive review of ALS. We cover all aspects of the disease including epidemiology, comorbidities, environmental risk factor, molecular mechanism, genetic factors, symptoms, diagnostic, treatment, and even the available supplement and management of ALS. This will provide the reader with an advantage of receiving a broad range of information about the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–319 of 319
Disease Course and Prognostic Factors of Progressive Muscular Atrophy
Visser, J., van den Berg‐Vos, R. M., Franssen, H., van den Berg, L. H., Wokke, J. H. J., de Jong, J. M. B. V., Holman, R., de Haan, R. J., & de Visser, M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.522 · Cited by 118
Ghadge, G. D., Slusher, B. S., Bodner, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530168100 · Cited by 118
The quality of care and symptom control — the effects on the terminal phase of ALS/MND
Oliver, D. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00087-1 · Cited by 117
Protective Effect of Parvalbumin on Excitotoxic Motor Neuron Death
Bosch, L. V. D., Schwaller, B., Vleminckx, V., Meijers, B. K. I., Stork, S., Ruehlicke, T., Houtte, E. V., Klaassen, H., Celio, M. R., Missiaen, L., et al. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7858 · Cited by 116
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis
Simpson, E. P., Yen, A. A., & Appel, S. H. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200311000-00008 · Cited by 115
Kuzuhara, S., Kokubo, Y., Sasaki, R., Narita, Y., Yabana, T., Hasegawa, M., & Iwatsubo, T. (2001) · Annals of Neurology · doi:10.1002/ana.100 · Cited by 115
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis
Körner, S., Kollewe, K., Ilsemann, J., Müller-Heine, A., Dengler, R., Krampfl, K., & Petri, S. (2012) · European Journal of Neurology · doi:10.1111/ene.12015 · Cited by 113
Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study
Schrooten, M., Smetcoren, C., Robberecht, W., & Damme, P. V. (2011) · Annals of Neurology · doi:10.1002/ana.22380 · Cited by 111
Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis
Cudkowicz, M., Shefner, J. M., Simpson, E., Grasso, D., Yu, H., Zhang, H., Shui, A. M., Schoenfeld, D., Brown, R. H., Wieland, S., et al. (2008) · Muscle & Nerve · doi:10.1002/mus.21059 · Cited by 110
SUBCUTANEOUS IGF-1 IS NOT BENEFICIAL IN 2-YEAR ALS TRIAL
Howe, C. L., Bergstrom, R. A., & Horazdovsky, B. F. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b26ae6 · Cited by 108
Short‐term trends in dementia prevalence in Germany between the years 2007 and 2009
Doblhammer, G., Fink, A., & Fritze, T. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.02.006 · Cited by 106
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
Rizzo, F., Riboldi, G. M., Salani, S., Nizzardo, M., Simone, C., Corti, S. P., & Hedlund, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1480-4 · Cited by 106
Depression in amyotrophic lateral sclerosis
Atassi, N., Cook, A., Pineda, C. M., Yerramilli-Rao, P., Pulley, D., & Cudkowicz, M. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.536839 · Cited by 106
Parboosingh, J. S., Figlewicz, D. A., Krizus, A., Meininger, V., Azad, N. A., Newman, D. S., & Rouleau, G. A. (1997) · Neurology · doi:10.1212/wnl.49.2.568 · Cited by 105
Age and founder effect of SOD1 A4V mutation causing ALS
Saeed, M., Yang, Y., Deng, H.-X., Hung, W.-Y., Siddique, N. A., Dellefave‐Castillo, L. M., Gellera, C., Andersen, P. M., & Siddique, T. (2009) · Neurology · doi:10.1212/01.wnl.0000343509.76828.2a · Cited by 104
Multiple System Atrophy: Pathophysiology and Management
Wenning, G. K., & Braune, S. (2001) · CNS Drugs · doi:10.2165/00023210-200115110-00003 · Cited by 104
MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons
Wang, W., Zhang, F., Li, L., Tang, F., Siedlak, S. L., Fujioka, H., Liu, Y., Su, B., Pi, Y., & Wang, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.617167 · Cited by 103
Football Increases the Risk for Lou Gehrig's Disease, Amyotrophic Lateral Sclerosis
Abel, E. L. (2007) · Perceptual and Motor Skills · doi:10.2466/pms.104.4.1251-1254 · Cited by 103
Mazzini, L., Balzarini, C., Colombo, R., Mora, G., Pastore, I., Ambrogio, R. D., & Caligari, M. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00611-6 · Cited by 103
Disruption of Axonal Transport in Motor Neuron Diseases
Ikenaka, K., Katsuno, M., Kawai, K., Ishigaki, S., Tanaka, F., & Sobue, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13011225 · Cited by 102
Meininger, V., Drory, V. E., Leigh, P. N., Ludolph, A. C., Robberecht, W., & Silani, V. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902803432 · Cited by 101
Bernard‐Marissal, N., Moumen, A., Sunyach, C., Pellegrino, C., Dudley, K., Henderson, C. E., Raoul, C., & Pettmann, B. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5431-11.2012 · Cited by 99
Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease
Orrell, R. W., Lane, R. J., & Ross, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002829.pub4 · Cited by 98 · cited 1×
“[273] Since Vitamin E or a-tocopherol functions as an antioxidant in neural cell membranes, there have been several studies testing its role in ALS.[74,106,197,224,225,227] In a research study by Gurney et al.”
BackgroundPain in Amyotrophic Lateral Sclerosis: A Neglected Aspect of Disease
Handy, C. R., Krudy, C. A., Boulis, N. M., & Federici, T. (2011) · Neurology Research International · doi:10.1155/2011/403808 · Cited by 98
Chung, M. J., & Suh, Y.-L. (2002) · Ultrastructural Pathology · doi:10.1080/01913120252934260 · Cited by 96
Clinical Characteristics and Management of ALS
Borasio, G. D., & Miller, R. G. (2001) · Seminars in Neurology · doi:10.1055/s-2001-15268 · Cited by 96
Offen, D., Barhum, Y., Melamed, E., Embacher, N., Schindler, C., & Ransmayr, G. N. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9004-z · Cited by 95
Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls
Honig, L. S., Chambliss, D. D., Bigio, E. H., Carroll, S. L., & Elliott, J. L. (2000) · Neurology · doi:10.1212/wnl.55.8.1082 · Cited by 92
Incidence and Prevalence of Amyotrophic Lateral Sclerosis in Uruguay: A Population-Based Study
Vázquez, C., Ketzoian, C. N., Legnani, C., Rega, I., Sánchez, N., Perna, A., Penela, M., Aguirrezábal, X., Druet‐Cabanac, M., & Medici, M. (2008) · Neuroepidemiology · doi:10.1159/000120023 · Cited by 92
Zhou, H., Chen, G., Chen, C., Yu, Y., & Xu, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048354 · Cited by 92
A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease
Orrell, R. W., Lane, R. J. M., & Ross, M. A. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960801900032 · Cited by 90
Metals in spinal cord tissue of patients dying of motor neuron disease
Kurlander, H. M., & Patten, B. M. (1979) · Annals of Neurology · doi:10.1002/ana.410060105 · Cited by 90
Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control
Palomo, G. M., & Manfredi, G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.065 · Cited by 89
Stommel, E. W., Cohen, J. A., Fadul, C. E., Cogbill, C. H., Graber, D. J., Kingman, L. S., MacKenzie, T. A., Smith, J. Y. C., & Harris, B. T. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802709416 · Cited by 88
A Novel Action of Histone Deacetylase Inhibitors in a Protein Aggresome Disease Model
Corcoran, L., Mitchison, T. J., & Liu, Q. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.003 · Cited by 87
Fatigue in amyotrophic lateral sclerosis: Frequency and associated factors
Ramirez, C., Piemonte, M. E. P., Callegaro, D., & da Silva, H. C. A. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701642502 · Cited by 87
Amyotrophic lateral sclerosis: toxins and environment
Mitchell, J. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515061 · Cited by 87
Kuzuhara, S., & Kokubo, Y. (2005) · Movement Disorders · doi:10.1002/mds.20548 · Cited by 84
Longitudinal predictors of psychological distress and self-esteem in people with ALS
Goldstein, L. H., Atkins, L., Landau, S., Brown, R. G., & Leigh, P. N. (2006) · Neurology · doi:10.1212/01.wnl.0000242886.91786.47 · Cited by 84
Newrick, P. G., & Langton-Hewer, R. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.8.838 · Cited by 81
van den Berg‐Vos, R. M., Visser, J., Kalmijn, S., Fischer, K., de Visser, M., de Jong, J. M. B. V., de Haan, R. J., Franssen, H., Wokke, J. H. J., & van den Berg, L. H. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.91 · Cited by 80
Clinical presentation and diagnosis of Amyotrophic Lateral Sclerosis
Ferguson, T. A., & Elman, L. B. (2007) · Neurorehabilitation · doi:10.3233/nre-2007-22602 · Cited by 79
Measures and markers in Amyotrophic Lateral Sclerosis
Cudkowicz, M., Qureshi, M., & Shefner, J. M. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.2.273 · Cited by 79
Ryberg, H., Askmark, H., & Persson, L. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00111.x · Cited by 79
Tedman, B., Young, C. A., & Williams, I. R. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00249-9 · Cited by 78
Motor neuron disease: systematic reviews of treatment for ALS and SMA
Orrell, R. W. (2009) · British Medical Bulletin · doi:10.1093/bmb/ldp049 · Cited by 78
Nefussy, B., Artamonov, I., Deutsch, V., Naparstek, E., Nagler, A., & Drory, V. E. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902933809 · Cited by 77
Meininger, V., Asselain, B. J. R., Guillet, P., Leigh, P. N., Ludolph, A. C., Lacomblez, L., & Robberecht, W. (2006) · Neurology · doi:10.1212/01.wnl.0000191326.40772.62 · Cited by 77
Tokuda, E., Ono, S.-I., Ishige, K., Watanabe, S., Okawa, E., Ito, Y., & Suzuki, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.011 · Cited by 76
Mitochondrial respiratory chain function in skeletal muscle of ALS patients
Echaniz‐Laguna, A., Zoll, J., Ribera, F., Tranchant, C., Warter, J., Lonsdorfer, J., & Lampert, E. (2002) · Annals of Neurology · doi:10.1002/ana.10357 · Cited by 75
Trías, E., Díaz‐Amarilla, P., Olivera‐Bravo, S., Isasi, E., Drechsel, D. A., Lopez, N. I., Bradford, C. S., Ireton, K. E., Beckman, J. S., & Barbeito, L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00274 · Cited by 73
Turner, M. R., Wotton, C. J., Talbot, K., & Goldacre, M. J. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301161 · Cited by 73
Fischbeck, K. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005344403603 · Cited by 73
Tovar‐y‐Romo, L. B., Zepeda, A., & Tapia, R. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181567c16 · Cited by 71
Kiaei, M. (2008) · PPAR Research · doi:10.1155/2008/418765 · Cited by 71
Kadoyama, K., Funakoshi, H., Ohya, W., & Nakamura, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.08.017 · Cited by 71
Prevalence of myocardial infarction and coronary heart disease in adults aged 40–79 years in Germany
Gößwald, A., Schienkiewitz, A., Nowossadeck, E., & Busch, M. A. (2013) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/1447 · Cited by 69
Diet and Amyotrophic Lateral Sclerosis
Morozova, N., Weisskopf, M. G., McCullough, M. L., Munger, K. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2008) · Epidemiology · doi:10.1097/ede.0b013e3181632c5d · Cited by 67
Current and emerging treatments for amyotrophic lateral sclerosis
Zoccolella (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s7788 · Cited by 67
Savolainen, K., Loikkanen, J. J., Eerikäinen, S., & Naarala, J. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00233-1 · Cited by 66
Jaiswal, M. K. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-26 · Cited by 65
Zhu, Y.-B., & Sheng, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237818 · Cited by 64
Martin, L. J. (2010) · PubMed · Cited by 63
Progressive apraxia of speech as a sign of motor neuron disease.
Duffy, J., Peach, R., & Strand, E. A. (2007) · American Journal of Speech-Language Pathology · doi:10.1044/1058-0360(2007/025 · Cited by 61
Martínez-Sámano, J., Torres-Durán, P. V., Juárez-Oropeza, M. A., & Verdugo‐Díaz, L. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.04.003 · Cited by 61
Shi, P., Ström, A., Gál, J., & Zhu, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.008 · Cited by 60
Diagnosis of muscle diseases presenting with early respiratory failure
Pfeffer, G., Povitz, M., Gibson, G. J., & Chinnery, P. F. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7526-1 · Cited by 59
Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly
Jaiswal, M. K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00199 · Cited by 57
The matrix metalloproteinases inhibitor Ro 26-2853 extends survival in transgenic ALS mice
Lorenzl, S., Narr, S., Angele, B., Krell, H. W., Gregorio, J., Kiaei, M., Pfister, H.-W., & Beal, M. F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.026 · Cited by 57
Al‐Sarraj, S., King, A., Cleveland, M. S., Pradat, P., Corse, A. M., Rothstein, J. D., Leigh, P., Abila, B., Bates, S., Würthner, J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0165-z · Cited by 57
Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis
Geevasinga, N., Menon, P., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2014) · European Journal of Neurology · doi:10.1111/ene.12422 · Cited by 56
Nobile‐Orazio, E. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.6.599 · Cited by 56
The effect of muscle dysfunction on bone mass and morphology.
Gross, T. S., Poliachik, S. L., Prasad, J., & Bain, S. D. (2010) · PubMed · Cited by 54
Progressive supranuclear palsy.
Duvoisin, R. C., Golbe, L. I., & Lepore, F. E. (1987) · PubMed · Cited by 54
Boston-Howes, W., Williams, E. O., Bogush, A. I., Scolere, M., Pasinelli, P., & Trotti, D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.010 · Cited by 52
Dubner, R. A., & Gold, M. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7627 · Cited by 51
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis
Freedman, D. M., Kuncl, R. W., Weinstein, S. J., Malila, N. K., Virtamo, J. R. K., & Albanes, D. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.745570 · Cited by 51
Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
Cozzolino, M., Rossi, S., Mirra, A., & Carrì, M. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00031 · Cited by 50
Orrell, R. W. (2006) · PubMed · Cited by 48
Al‐Chalabi, A., & Leigh, P. N. (2005) · Brain · doi:10.1093/brain/awh426 · Cited by 48
Gößwald, A., Schienkiewitz, A., Nowossadeck, E., & Busch, M. A. (2013) · European Journal of Public Health · doi:10.1093/eurpub/ckt123.055 · Cited by 47
Reisin, R. C. (2012) · Yearbook of Neurology and Neurosurgery · doi:10.1016/j.yneu.2012.05.040 · Cited by 46
Lauria, G., Campanella, A., Filippini, G., Martini, A., Penza, P., Maggi, L., Antozzi, C. G., Ciano, C., Beretta, P., Caldiroli, D., et al. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902995246 · Cited by 45
Serum levels of coenzyme Q 10 in patients with amyotrophic lateral sclerosis
Molina, J. A., de Bustos, F., Jiménez‐Jiménez, F. J., Gómez-Escalonilla, C., García‐Redondo, A., Esteban, J., Guerrero-Sola, A., del Hoyo, P., Martínez‐Salio, A., Ramírez-Ramos, C., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070050 · Cited by 43
Cheah, B. C., & Kiernan, M. C. (2010) · PubMed · Cited by 41
Mitsumoto, H., Factor-Litvak, P. R., Andrews, H., Goetz, R. R., Andrews, L. R., Rabkin, J. G., McElhiney, M. C., Nieves, J. W., Santella, R. M., Murphy, J. M., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.864312 · Cited by 40
Trial of Baclofen in Amyotrophic Lateral Sclerosis
Norris, F. H., Kim, U., Sachais, B. A., & Carey, M. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500470085019 · Cited by 38
Deivasigamani, S., Verma, H., Ueda, R., Ratnaparkhi, A., & Ratnaparkhi, G. S. (2014) · Biology Open · doi:10.1242/bio.201410066 · Cited by 35
Plasma amino acids concentration in amyotrophic lateral sclerosis patients
Iłżecka, J., Stelmasiak, Z., Solski, J., Wawrzycki, S., & Szpetnar, M. (2003) · Amino Acids · doi:10.1007/s00726-002-0352-2 · Cited by 34
He, J., Mangelsdorf, M., Fan, D., Bartlett, P. F., & Brown, M. A. (2014) · The Neuroscientist · doi:10.1177/1073858414555404 · Cited by 34
Consistency of the Babinski reflex and its variants
Singerman, J., & Lee, L. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02219.x · Cited by 33
Potential Treatment of Amyotrophic Lateral Sclerosis with Gabapentin: A Hypothesis
Welty, D. F., Schielke, G. P., & Rothstein, J. D. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502901118 · Cited by 32
Yu, Y., Hayashi, S., Cai, X., Fang, C., Shi, W., Tsutsui, H., & Sheng, J. (2014) · BioMed Research International · doi:10.1155/2014/254680 · Cited by 30
Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS
Azari, M. F., Profyris, C., Grande, M. R. L., Lopes, E. C., Hirst, J. J., Petratos, S., & Cheema, S. S. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00987.x · Cited by 29
Sanjak, M., Konopacki, R. A., Capasso, R., Roelke, K., Peper, S., Houdek, A., Waclawik, A., & Br, B. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310017551 · Cited by 29
Jackson, M., & Rothstein, J. D. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_16 · Cited by 29
Xaliproden in amyotrophic lateral sclerosis: early clinical trials
Lacomblez, L., Bensimon, G., Douillet, P., Doppler, V., Salachas, F., & Meininger, V. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410018973 · Cited by 27
Dangoumau, A., Verschueren, A., Hammouche, E., Papon, M.-A., Blasco, H., Antar, C., Pouget, J., Corcia, P., Andres, C. R., & Vourc’h, P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.012 · Cited by 27
Neuroprotective agents for clinical trials in ALS: A systematic assessment
Burke, W. J. (2007) · Neurology · doi:10.1212/01.wnl.0000258815.56062.43 · Cited by 25
Garber, K. (2008) · Science · doi:10.1126/science.319.5859.20 · Cited by 24
Excitation BolsTORs Motor Neurons in ALS Mice
Mattson, M. P. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.017 · Cited by 21
Molecular and Cellular Mechanism of Glutamate Receptors in Relation to Amyotrophic Lateral Sclerosis
Iwasaki, B. S. P. Y., Ikeda, B. S. P. K., & Kinoshita, B. S. P. M. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339021 · Cited by 19
Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis
Blatzheim, K. (2008) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2008.04.040 · Cited by 18
Simmons, A. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608299750138777 · Cited by 18
Amyotrophic lateral sclerosis with supranuclear ophthalmoplegia and rigidity
Kobayashi, M., Ikeda, K., Kinoshita, M., & Iwasaki, Y. (1999) · Neurological Research · doi:10.1080/01616412.1999.11740994 · Cited by 17
de Paulis, T. (2003) · PubMed · Cited by 14
Amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Hortobágyi, T., & Cairns, N. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.012 · Cited by 14
Tröster, A. I. (2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_514 · Cited by 14
CERVICAL SPONDYLOTIC MYELOPATHY
Benzel, E. C. (1996) · Neurosurgical FOCUS · doi:10.3171/foc.1996.1.6.3 · Cited by 13
Fatigue and depression are associated with poor quality of life in ALS
Abe, K. (2004) · Neurology · doi:10.1212/wnl.62.10.1914 · Cited by 10
Nefussy, B., Artamonov, I., Deutsch, V. R., Naparstek, E., Nagler, A., & Drory, V. E. (2009) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960902933809 · Cited by 9
Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination
Carilho, R., de Carvalho, M. A., Kuehl, U., Pinto, S., Pinto, A. C., Kromminga, A., & Costa, J. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.584881 · Cited by 8
hSOD1 Promotes Tau Phosphorylation and Toxicity in the Drosophila Model
Huang, Y., Wu, Z., & Zhou, B. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141608 · Cited by 7
Multiple Routes of Motor Neuron Degeneration in ALS
Hee, J., & Keun, J. S. (2013) · InTech eBooks · doi:10.5772/56625 · Cited by 5
Alavi, A., Khani, M., Nafissi, S., Shamshiri, H., & Elahi, E. (2014) · PubMed Central · Cited by 3
Kleopa, K. A. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch12 · Cited by 3
Progressive supranuclear palsy
Moore, C. L. H., & Singer, C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977749.003 · Cited by 2
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Unraveling the molecular mechanism underlying ALS-linked astrocyte toxicity for motor neurons
Ikiz, B. (2013) · doi:10.7916/d8db87x7 · Cited by 1
Cited by
Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules
Markmiller, S., Soltanieh, S., Server, K. L., Mak, R., Jin, W., Fang, M. Y., Luo, E.-C., Krach, F., Yang, D., Sen, A., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.032 · Cited by 911
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Roles of neuropathology-associated reactive astrocytes: a systematic review
Lawrence, J. M., Schardien, K., Wigdahl, B., & Nonnemacher, M. R. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01526-9 · Cited by 433
Liu, J., & Wang, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01005 · Cited by 376
Metadata
- Authors
- Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A.
- Venue
- Surgical Neurology International
- Publisher
- Scientific Scholar
- Published
- 2015
- Volume
- 6
- Issue
- 1
- Pages
- 171
- ISSN
- 2152-7806 (ISSN-L)
- OpenAlex
- W2186898572
- Cited by
- 709
- References
- 319
- FWCI
- 25.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.